George J. Walsh III
Chairman of the Board at CHEMED
Board
About George J. Walsh III
Independent director of Chemed Corporation since 1995 and current Chairman of the Board. Age 79. Career corporate attorney: former partner at Thompson Hine LLP (New York) until retirement in December 2024; previously partner at Gould & Wilkie LLP (merged into Thompson Hine in 2002). Elected Chairman of the Board in March 2009, with ongoing governance leadership at CHE .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Thompson Hine LLP (NY) | Partner | May 2002 – Dec 2024 (retired) | Corporate legal expertise; merger lineage from Gould & Wilkie |
| Gould & Wilkie LLP (NY) | Partner | Jan 1979 – May 2002 | Firm merged into Thompson Hine on May 1, 2002 |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| None disclosed | — | — | No current or prior public company directorships disclosed for Walsh beyond CHE |
Board Governance
| Attribute | Detail |
|---|---|
| Independence | Board determined Walsh is independent under NYSE standards |
| Board role | Chairman of the Board (functions separated from CEO) |
| Director tenure | Director since 1995 |
| Committees | Compensation Committee Chair; Nominating Committee member |
| Committee meetings in 2024 | Compensation: 3; Nominating: 1 |
| Board meetings in 2024 | 5 meetings; all directors attended at least 80% of Board and applicable committee meetings |
| Executive sessions | Board meets in executive session each meeting without executives/management; sessions presided over by Chairman |
| Majority voting | Majority vote standard; irrevocable resignation policy for incumbent directors not receiving majority support |
Fixed Compensation
| Component (2024) | Amount ($) | Notes |
|---|---|---|
| Annual director retainer | 80,000 | Non-employee directors |
| Chairman of the Board retainer | 145,000 | Additional fee for Walsh as Chairman |
| Compensation Committee Chair fee | 20,000 | Chair premium |
| Compensation Committee membership fee | 12,000 | For members (non-chair) |
| Nominating Committee membership fee | 10,000 | For members (non-chair) |
| Board meeting fee (per meeting) | 3,000 | Paid per Board meeting |
| Committee meeting fee (per meeting) | 1,000 (or 500 if same day as Board) | Paid per Committee meeting |
| Total cash paid (Walsh, 2024) | 275,000 | As reported in Director Compensation Table |
| Perquisites (Walsh, 2024) | 39,578 | Personal use of company aircraft (incremental cost basis) |
Performance Compensation
| Equity/Deferral Program | Date | Units/Shares | Amount ($) | Vesting/Terms |
|---|---|---|---|---|
| Annual fully vested stock award | May 2024 | 284 | ~160,273 | Fully vested; granted under 2018/2022 Stock Incentive Plans |
| Director Deferred Compensation Plan contribution | 2024 | N/A | 6,000 | Quarterly credits used to purchase CHE stock; dividends reinvested; payable within 90 days post-service |
| Performance Metrics Applied to Director Pay | Target | Weight | Payout | Notes |
|---|---|---|---|---|
| None (director equity grants are fully vested) | — | — | — | Non-employee directors do not have performance-conditioned awards |
Other Directorships & Interlocks
| Category | Detail |
|---|---|
| Compensation Committee composition | Walsh (Chair), Heaney, Lindell, McCarthy |
| Interlocks | No compensation committee interlocks or insider participation disclosed in 2024 |
| Other public company boards (Walsh) | None disclosed |
Expertise & Qualifications
- Corporate law partner since 1979; governance and legal risk expertise .
- Board leadership: Chairman of the Board since March 2009; supports separation of CEO/Chair roles .
- Compensation oversight experience as Compensation Committee Chair .
- Board policy stewardship in majority voting, related-party transaction review, and ethics/insider trading policies .
Equity Ownership
| Ownership Category (as of 12/31/2024) | Shares/Units | Notes |
|---|---|---|
| Direct & Thrift Plan | 3,046 | Beneficial ownership table |
| Options exercisable (≤60 days) | 0 | None disclosed for Walsh |
| Trusteeships/Family holdings | 0 | None disclosed for Walsh |
| Total beneficial ownership | 3,046 | Under 1% of class; company does not show exact % <1% |
| Approximate market value | ~$1,613,771 | 3,046 shares at $529.80 close on 12/31/2024 |
| Ownership guideline | $400,000 required (5× $80,000 retainer) | Directors must retain holdings ≥ $400,000; company reports directors meet or are on track |
Governance Assessment
- Strengths
- Independent Chairman; CEO/Chair separation enhances oversight .
- Majority voting with resignation policy; shareholder-friendly director election standard .
- Strong attendance (≥80% Board/committee) and participation; Walsh attended 2024 Annual Meeting .
- Compensation Committee practices: independent consultant (Compensation Strategies, Inc.) and 2025 independence review concluded no conflicts .
- Clawback policy (NYSE-compliant) and anti-hedging policy in place; reduces risk of misaligned incentives .
- Say-on-pay support: 82.70% in 2024, reflecting investor acceptance of compensation oversight by the committee Walsh chairs .
- Risks and potential red flags
- Very long tenure (director since 1995) and age 79—facts that can prompt board refreshment questions among some investors .
- Personal use of company aircraft ($39,578 in 2024) is a notable perquisite for a director; investors may scrutinize perq policies despite incremental cost accounting .
- Concentration of influence: Walsh is both Board Chairman and Compensation Committee Chair, which some investors monitor closely for checks/balances (facts: roles as Chair of Board and of Compensation Committee) .
- Related-party transactions and conflicts
- No related-party transactions disclosed for Walsh; company maintains formal related person transaction review policy .
- Section 16(a) compliance: no delinquent filings noted for Walsh; one director (Lindell) had a late filing; none for Walsh .
Director compensation mix (Walsh 2024): Cash $275,000 (≈57%), Stock $166,273 (≈35%), Perqs $39,578 (≈8%), Total $480,851—equity grants are fully vested and not performance-conditioned .
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%